Kim M. Keeling, Ph.D.

Affiliations: 
2000 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Genetics, Molecular Biology
Google:
"Kim Keeling"

Parents

Sign in to add mentor
David M. Bedwell grad student 2000 UAB
 (Suppression of premature stop mutations using aminoglycosides.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Leier A, Bedwell DM, Chen AT, et al. (2020) Mutation-Directed Therapeutics for Neurofibromatosis Type I. Molecular Therapy. Nucleic Acids. 20: 739-753
Keeling KM, Bedwell DM. (2020) Finding sense in the context. Elife. 9
Xue X, Mutyam V, Thakerar A, et al. (2017) Identification of the Amino Acids Inserted During Suppression of CFTR Nonsense Mutations and Determination of Their Functional Consequences. Human Molecular Genetics
Roy B, Friesen WJ, Tomizawa Y, et al. (2016) Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression. Proceedings of the National Academy of Sciences of the United States of America
Mutyam V, Du M, Xue X, et al. (2016) Discovery of Clinically Approved Agents That Promote Suppression of CFTR Nonsense Mutations. American Journal of Respiratory and Critical Care Medicine
Keeling KM, Xue X, Gunn G, et al. (2014) Therapeutics based on stop codon readthrough. Annual Review of Genomics and Human Genetics. 15: 371-94
Gunn G, Dai Y, Du M, et al. (2014) Long-term nonsense suppression therapy moderates MPS I-H disease progression. Molecular Genetics and Metabolism. 111: 374-81
Keeling KM, Wang D, Dai Y, et al. (2013) Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression. Plos One. 8: e60478
Keeling KM, Wang D, Conard SE, et al. (2012) Suppression of premature termination codons as a therapeutic approach. Critical Reviews in Biochemistry and Molecular Biology. 47: 444-63
Wang D, Belakhov V, Kandasamy J, et al. (2012) The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse. Molecular Genetics and Metabolism. 105: 116-25
See more...